Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
13.92
-0.09 (-0.64%)
At close: May 12, 2025, 4:00 PM
13.92
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Cross Country Healthcare Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Cross Country Healthcare stock have an average target of 18.41, with a low estimate of 18 and a high estimate of 18.61. The average target predicts an increase of 32.26% from the current stock price of 13.92.
Analyst Consensus: Buy
* Price targets were last updated on Mar 14, 2025.
Analyst Ratings
The average analyst rating for Cross Country Healthcare stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +33.69% | Mar 14, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 6, 2025 |
| Barrington Research | Barrington Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 10, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $15 → $19 | Hold | Maintains | $15 → $19 | +33.69% | Dec 5, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +29.31% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
1.27B
from 1.34B
Decreased by -5.80%
Revenue Next Year
1.32B
from 1.27B
Increased by 4.50%
EPS This Year
0.39
from -0.44
EPS Next Year
0.55
from 0.39
Increased by 42.11%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.3B | 1.4B | 1.4B |
| Avg | 1.3B | 1.3B | 1.4B |
| Low | 1.2B | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.0% | 11.1% | 7.9% |
| Avg | -5.8% | 4.5% | 4.9% |
| Low | -13.6% | -3.1% | 0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.55 | 0.71 | 0.64 |
| Avg | 0.39 | 0.55 | 0.62 |
| Low | 0.22 | 0.37 | 0.60 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 84.9% | 16.7% |
| Avg | - | 42.1% | 13.4% |
| Low | - | -3.6% | 8.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.